Caficrestat

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameCaficrestat
Drug Alias NameAT-001AT001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetic Cardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[10
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesApplied Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetic Cardiomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A